NFKB1 and colorectal cancer: To investigate the molecular mechanism underlying YG-22’s inhibition of the colorectal cancer cell line HCT116, we performed a multi-omics analysis, including transcriptome, metabolome, chromatin accessibility, H3K4Me3 histone methylation, and NF-κB binding site analyses.